Cargando…
Rosuvastatin treatment alone cannot alleviate lupus in murine model: a pilot study
OBJECTIVE: Systemic lupus erythematosus (SLE) is an autoimmune disease, characterized by the production of autoantibodies and high cholesterol levels. HMG-CoA (3-hydroxy-3-methylglutaryl-coenzyme A) reductase inhibitors have exhibited anti-inflammatory effects in several clinical trials. We conducte...
Autores principales: | Baek, Wook-Young, Lee, Sung-Min, Lee, Sang-Won, Suh, Chang-Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean College of Rheumatology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351369/ https://www.ncbi.nlm.nih.gov/pubmed/37476679 http://dx.doi.org/10.4078/jrd.2023.0021 |
Ejemplares similares
-
Intravenous Administration of Toll-Like Receptor Inhibitory Peptide 1 is Effective for the Treatment of Systemic Lupus Erythematosus in a Mus musculus Model
por: Baek, Wook-Young, et al.
Publicado: (2021) -
Incidence and outcomes of cricothyrotomy in the “cannot intubate, cannot oxygenate” situation
por: Kwon, Young Suk, et al.
Publicado: (2019) -
S100A8 in Serum, Urine, and Saliva as a Potential Biomarker for Systemic Lupus Erythematosus
por: Kim, Ji-Won, et al.
Publicado: (2022) -
Increased Immunoglobulin Gamma-3 Chain C in the Serum, Saliva, and Urine of Patients with Systemic Lupus Erythematosus
por: Jung, Ju-Yang, et al.
Publicado: (2023) -
Melatonin combined with exercise cannot alleviate cerebral injury in a rat model of focal cerebral ischemia/reperfusion injury
por: Lee, Seunghoon, et al.
Publicado: (2012)